The Intersection between Tumor Angiogenesis and Immune Suppression von Rahma, Osama E, Hodi, F Stephen

Volltext

Monitoring immune-checkpoint blockade: response evaluation and biomarker development von Nishino, Mizuki, Ramaiya, Nikhil H., Hatabu, Hiroto, Hodi, F. Stephen

Volltext

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain von Tawbi, Hussein A, Forsyth, Peter A, Algazi, Alain, Hamid, Omid, Hodi, F. Stephen, Moschos, Stergios J, Khushalani, Nikhil I, Lewis, Karl, Lao, Christopher D, Postow, Michael A, Atkins, Michael B, Ernstoff, Marc S, Reardon, David A, Puzanov, Igor, Kudchadkar, Ragini R, Thomas, Reena P, Tarhini, Ahmad, Pavlick, Anna C, Jiang, Joel, Avila, Alexandre, Demelo, Sheena, Margolin, Kim

Volltext

Molecular Pathways: Next-Generation Immunotherapy― Inhibiting Programmed Death-Ligand 1 and Programmed Death-1 von CHEN, Daniel S, IRVING, Bryan A, STEPHEN HODI, F

Volltext

Imaging of Cancer Immunotherapy: Current Approaches and Future Directions von Nishino, Mizuki, Hatabu, Hiroto, Hodi, F Stephen

Volltext

Metabolomic adaptations and correlates of survival to immune checkpoint blockade von Li, Haoxin, Bullock, Kevin, Gurjao, Carino, Braun, David, Shukla, Sachet A., Bossé, Dominick, Lalani, Aly-Khan A., Gopal, Shuba, Jin, Chelsea, Horak, Christine, Wind-Rotolo, Megan, Signoretti, Sabina, McDermott, David F., Freeman, Gordon J., Van Allen, Eliezer M., Schreiber, Stuart L., Stephen Hodi, F., Sellers, William R., Garraway, Levi A., Clish, Clary B., Choueiri, Toni K., Giannakis, Marios

Volltext

Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade von Buchbinder, Elizabeth, Hodi, F Stephen

Volltext

Hepatotoxicity with Combination of Vemurafenib and Ipilimumab von Ribas, Antoni, Hodi, F. Stephen, Callahan, Margaret, Konto, Cyril, Wolchok, Jedd

Volltext

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy von Hodi, F Stephen, Ballinger, Marcus, Lyons, Benjamin, Soria, Jean-Charles, Nishino, Mizuki, Tabernero, Josep, Powles, Thomas, Smith, David, Hoos, Axel, McKenna, Chris, Beyer, Ulrich, Rhee, Ina, Fine, Gregg, Winslow, Nathan, Chen, Daniel S, Wolchok, Jedd D

Volltext

Ipilimumab and Its Toxicities: A Multidisciplinary Approach von Fecher, Leslie A., Agarwala, Sanjiv S., Hodi, F. Stephen, Weber, Jeffrey S.

Volltext

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity von Ferrari de Andrade, Lucas, Tay, Rong En, Pan, Deng, Luoma, Adrienne M, Ito, Yoshinaga, Badrinath, Soumya, Tsoucas, Daphne, Franz, Bettina, May, Jr, Kenneth F, Harvey, Christopher J, Kobold, Sebastian, Pyrdol, Jason W, Yoon, Charles, Yuan, Guo-Cheng, Hodi, F Stephen, Dranoff, Glenn, Wucherpfennig, Kai W

Volltext

The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition von XIAOFENG JIANG, JUN ZHOU, GIOBBIE-HURDE, Anita, WARGO, Jennifer, STEPHEN HODI, F

Volltext

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma von Schadendorf, Dirk, Hodi, F Stephen, Robert, Caroline, Weber, Jeffrey S, Margolin, Kim, Hamid, Omid, Patt, Debra, Chen, Tai-Tsang, Berman, David M, Wolchok, Jedd D

Volltext

Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints von Chang, Lee-Shing, Barroso-Sousa, Romualdo, Tolaney, Sara M, Hodi, F Stephen, Kaiser, Ursula B, Min, Le

Volltext

Ipilimumab for Patients with Relapse after Allogeneic Transplantation von Davids, Matthew S, Kim, Haesook T, Bachireddy, Pavan, Costello, Caitlin, Liguori, Rebecca, Savell, Alexandra, Lukez, Alexander P, Avigan, David, Chen, Yi-Bin, McSweeney, Peter, LeBoeuf, Nicole R, Rooney, Michael S, Bowden, Michaela, Zhou, Chensheng W, Granter, Scott R, Hornick, Jason L, Rodig, Scott J, Hirakawa, Masahiro, Severgnini, Mariano, Hodi, F. Stephen, Wu, Catherine J, Ho, Vincent T, Cutler, Corey, Koreth, John, Alyea, Edwin P, Antin, Joseph H, Armand, Philippe, Streicher, Howard, Ball, Edward D, Ritz, Jerome, Bashey, Asad, Soiffer, Robert J

Volltext

Talimogene Laherparepvec for the Treatment of Advanced Melanoma von Ott, Patrick A, Hodi, F Stephen

Volltext

Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy von Nishino, Mizuki, Sholl, Lynette M, Hatabu, Hiroto, Ramaiya, Nikhil H, Hodi, F. Stephen

Volltext

PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course von Nishino, Mizuki, Ramaiya, Nikhil H, Awad, Mark M, Sholl, Lynette M, Maattala, Jennifer A, Taibi, Myriam, Hatabu, Hiroto, Ott, Patrick A, Armand, Philippe F, Hodi, F Stephen

Volltext

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized... von Schadendorf, Dirk, Wolchok, Jedd D, Hodi, F Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C Lance, Lao, Christopher D, Chesney, Jason, Robert, Caroline, Grossmann, Kenneth, McDermott, David, Walker, Dana, Bhore, Rafia, Larkin, James, Postow, Michael A

Volltext

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria von WOLCHOK, Jedd D, HOOS, Axel, HUMPHREY, Rachel, STEPHEN HODI, F, O'DAY, Steven, WEBER, Jeffrey S, HAMID, Omid, LEBBE, Celeste, MAIO, Michele, BINDER, Michael, BOHNSACK, Oliver, NICHOL, Geoffrey

Volltext